{
    "organizations": [],
    "uuid": "60a5d117b3109cd3a74d8a112d3a9b589918c092",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-heidelberg-pharma-and-advanced-pro/brief-heidelberg-pharma-and-advanced-proteome-therapeutics-progress-collaborative-program-idUSFWN1P30VV",
    "ord_in_thread": 0,
    "title": "BRIEF-Heidelberg Pharma And Advanced Proteome Therapeutics Progress Collaborative Program",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 8 (Reuters) - HEIDELBERG PHARMA AG:\n* DGAP-NEWS: HEIDELBERG PHARMA AG AND ADVANCED PROTEOME THERAPEUTICS PROGRESS COLLABORATIVE PROGRAM Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-01-09T01:06:00.000+02:00",
    "crawled": "2018-01-09T17:18:50.010+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "heidelberg",
        "pharma",
        "ag",
        "heidelberg",
        "pharma",
        "ag",
        "advanced",
        "proteome",
        "therapeutic",
        "progress",
        "collaborative",
        "program",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}